Astragaloside IV enhances autophagy to suppress endoplasmic reticulum stress and pyroptosis after spinal cord injury
Cellular Signalling · 2026-09 · 145 · 112571
DOI: 10.1016/j.cellsig.2026.112571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-09. Verfasst von Zhichen Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China; Zheji…. Hauptthemen laut MEDLINE: Triterpenes, Saponins, Spinal Cord Injuries, Autophagy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Ningbo Municipality, National Natural Science Foundation of China, Medical and Health Research Project of Zhejiang Province.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a devastating insult to the central nervous system that causes severe motor and sensory dysfunction; however, effective therapeutic strategies remain limited because the mechanisms underlying secondary injury are not fully understood. In this study, we investigated the therapeutic effects of the bioactive compound astragaloside IV (AST-IV) in a mouse model of SCI. Through functional, histological, and molecular analyses, we demonstrated that AST-IV treatment significantly improved neurological recovery after SCI. Mechanistically, AST-IV exerted neuroprotective effects through the activation of AMPK-mediated autophagy and the enhancement of autophagic flux, thereby preserving mitochondrial homeostasis, attenuating endoplasmic reticulum stress-associated apoptosis, and suppressing pyroptosis. Importantly, pharmacological inhibition of autophagy markedly attenuated the protective effects of AST-IV, indicating that the neuroprotective effect of AST-IV is mediated by autophagy. Collectively, these findings reveal an autophagy-dependent mechanism underlying AST-IV-mediated neuroprotection and support the therapeutic potential of AST-IV for mitigating secondary injury after SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China; Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China;…
- The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China.
Förderung
- Natural Science Foundation of Ningbo Municipality
- National Natural Science Foundation of China
- Medical and Health Research Project of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Jiang, Z., Wu, Z., Jin, Y., Xu, K., Shu, W., Wu, Y., Ying, J., Wu, J., Geng, Y., Hong, C., Shi, J., Wang, C., Zhou, K., Qi, J., & Xu, H. (2026). Astragaloside IV enhances autophagy to suppress endoplasmic reticulum stress and pyroptosis after spinal cord injury. Cellular Signalling, 145, 112571. https://doi.org/10.1016/j.cellsig.2026.112571
Vancouver
Jiang Z, Wu Z, Jin Y, Xu K, Shu W, Wu Y, et al. Astragaloside IV enhances autophagy to suppress endoplasmic reticulum stress and pyroptosis after spinal cord injury. Cellular Signalling. 2026;145:112571. doi:10.1016/j.cellsig.2026.112571
BibTeX
@article{Jiang2026,
author = {Jiang, Zhichen and Wu, Zhouwei and Jin, Yuchen and Xu, Keming and Shu, Weizhi and Wu, Yuzhe and Ying, Juntao and Wu, Junhao and Geng, Yibo and Hong, Chenglong and Shi, Jingwei and Wang, Chenggui and Zhou, Kailiang and Qi, Jianjun and Xu, Hui},
title = {Astragaloside IV enhances autophagy to suppress endoplasmic reticulum stress and pyroptosis after spinal cord injury},
journal = {Cellular Signalling},
year = {2026},
volume = {145},
pages = {112571},
doi = {10.1016/j.cellsig.2026.112571}
}
EUVIMED